Medifast Q2 EPS $2.77 Beats $1.44 Estimate, Sales $296.19M Beat $253.47M Estimate
Portfolio Pulse from Benzinga Newsdesk
Medifast reported Q2 earnings of $2.77 per share, beating the analyst consensus estimate of $1.44 by 92.36%. However, this is a decrease from $3.42 per share from the same period last year. The company also reported quarterly sales of $296.19 million, beating the analyst consensus estimate of $253.47 million by 16.85%, but this is a 34.66% decrease from the same period last year.
August 07, 2023 | 8:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Medifast's Q2 earnings and sales beat estimates but showed a decrease from the same period last year. This mixed result could lead to uncertainty in the market.
Medifast's earnings and sales beat estimates, which is generally positive for the stock. However, the decrease from the same period last year could be a concern for investors, leading to potential uncertainty in the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100